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background: Thoracic aortic aneurysm (TAA) formation is the leading cause of morbidity and mortality in Marfan Syndrome. In addition to aberrant 
transforming growth factor-β signaling, angiotensin II type 1a receptor (AT1AR)-mediated signaling including activation of mitogen activated protein 
kinases (MAPK) contributes to TAA development in Marfan Syndrome. Given that β-arrestin2 (βarr2) is known to mediate AT1AR-dependent MAPK 
activation, we hypothesized that βarr2 may contribute to TAA formation in Marfan Syndrome.
Methods: Fbn1C1039G/+ mice, a murine model of TAA formation in Marfan Syndrome, were crossed with βarr2-/- mice and followed every 
4 weeks by echocardiography to assess TAA formation. Aortic root tissue from these animals was analyzed by quantitative PCR and Western 
blot. Finally, primary thoracic aortic vascular smooth muscle cells treated with angiotensin II or the AT1AR βarr2-biased agonist TRV023 were 
analyzed by quantitative PCR and Western blot.
results: Fbn1C1039G/+/βarr2-/- animals exhibited significantly delayed TAA growth compared to Fbn1C1039G/+ animals, particularly at early 
time points. In addition, significantly reduced mRNA and protein expression of multiple pro-fibrotic genes/proteins known to be involved in TAA 
formation in Marfan Syndrome such as matrix metalloproteinase (MMP) 2 and 9 and monocyte chemotactic protein (MCP)-1 was observed in aortic 
tissue of Fbn1C1039G/+/βarr2-/- mice compared to Fbn1C1039G/+ mice. Stimulation of vascular smooth muscle cells with angiotensin II or 
TRV023 significantly increased mRNA expression of several pro-fibrotic genes including MMP2, MMP9, and MCP-1. Extracellular-regulated kinase 
1/2 blockade as well as small interfering RNA targeting βarr2 inhibited this expression whereas blockade of the transforming growth factor-β 
receptor had no affect on gene expression.
conclusions: βarr2 contributes to TAA formation in Marfan Syndrome by mediating MAPK activation and subsequent expression of pro-fibrotic 
genes downstream of the AT1AR. This represents a unique pathogenic signaling pathway in TAA formation in Marfan Syndrome and identifies βarr2 as 
a novel therapeutic target for inhibition.
